SavedAdd your journal

Journals / Molecular Oncologic Imaging / 2026 / Volume: 3 Issue: 2

Mortality Analysis by Means of F-18 FDG PET/CT in High Grade Extranodal Head and Neck Lymphoma

Zehra Pınar Koç(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, NÜKLEER TIP ANABİLİM DALI)
Pelin Özcan Kara(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, NÜKLEER TIP ANABİLİM DALI)0000-0003-0147-2678
Emel Sezer(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, İÇ HASTALIKLARI ANABİLİM DALI, TIBBİ ONKOLOJİ BİLİM DALI)0000-0001-9881-3533
Aydan Akdeniz(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, İÇ HASTALIKLARI ANABİLİM DALI, HEMATOLOJİ BİLİM DALI)0000-0002-5160-4803
Gülhan Temel(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, TEMEL TIP BİLİMLERİ BÖLÜMÜ, BİYOİSTATİSTİK VE TIBBİ BİLİŞİM ANABİLİM DALI)0000-0002-2835-6979
Pages
—
Publication Date
2023-09-13
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This analysis demonstrated that the mortality of the patients with high grade head and neck ENL might not be predicted by means of initial SUVmax levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study is to decide the diagnostic value of F-18 FDG PET/CT in the predictive value of survival of the patients with diagnosis of head and neck extranodal lymphoma (ENL).
📊
Key Findings & Data:Materials and Methods: Eighteen patients (10 F, 8 M; mean: 54,3±21.1 years old) with the diagnosis of head and neck ENL were included in the study.
💡
Conclusion & Impact:This analysis demonstrated that the mortality of the patients with high grade head and neck ENL might not be predicted by means of initial SUVmax levels.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:lymphoma · extranodal · FDG

Abstract

The aim of this study is to decide the diagnostic value of F-18 FDG PET/CT in the predictive value of survival of the patients with diagnosis of head and neck extranodal lymphoma (ENL). Materials and Methods: Eighteen patients (10 F, 8 M; mean: 54,3±21.1 years old) with the diagnosis of head and neck ENL were included in the study. The FDG PET/CT images of the patients were analyzed retrospectively and the maximum standardized uptake value (SUVmax) levels of the primary tumors at the initial evaluation were recorded and compared with mortality results of the patients in the follow up. Results: The initial SUVmax levels of the patients with progressive and stable-responsive disease were not significantly different and the difference between the SUVmax levels of the patients who died was not statistically significant. Discussion and Conclusion: FDG PET/CT is the gold standard imaging modality in the diagnosis and follow up of the lymphoma. Head and neck ENL is a special group of lymphoma with different prognosis. This analysis demonstrated that the mortality of the patients with high grade head and neck ENL might not be predicted by means of initial SUVmax levels.

🔖

Cite This Article

Koç, Z. P., Kara, P. Ö., Sezer, E., Akdeniz, A., Temel, G. (2023). Mortality Analysis by Means of F-18 FDG PET/CT in High Grade Extranodal Head and Neck Lymphoma. Molecular Oncologic Imaging, Volume: 3 Issue: 2. https://ajindex.com/articles/1626543

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (26)

  1. Broadwater, D. R., & Peker, D. (2018). Systemic Non-Hodgkin T Cell Lymphomas Presenting in the Head and Neck Region: An Institutional Experience of a Rare Entity. Head and neck pathology, 12(4), 481–487. https://doi.org/10.1007/s12105-017-0881-3
  2. Siddiqui, N. A., Branstetter, B. F., 4th, Hamilton, B. E., Ginsberg, L. E., Glastonbury, C. M., Harnsberger, H. R., Barnes, E. L., & Myers, E. N. (2010). Imaging characteristics of primary laryngeal lymphoma. AJNR. American journal of neuroradiology, 31(7), 1261–1265. https://doi.org/10.3174/ajnr.A2085
  3. Zhang, M. J., Jiang, J. J., Jiang, M. S., & He, W. (2010). F-18 FDG PET/CT in primary tonsillar lymphoma. Clinical nuclear medicine, 35(9), 710–712. https://doi.org/10.1097/RLU.0b013e3181e9fc29
  4. Ilica, A. T., Kocacelebi, K., Savas, R., & Ayan, A. (2011). Imaging of extranodal lymphoma with PET/CT. Clinical nuclear medicine, 36(10), e127–e138. https://doi.org/10.1097/RLU.0b013e31821c99cd
  5. Suh, C., Kang, Y. K., Roh, J. L., Kim, M. R., Kim, J. S., Huh, J., Lee, J. H., Jang, Y. J., & Lee, B. J. (2008). Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck. Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 49(11), 1783–1789. https://doi.org/10.2967/jnumed.108.053355
  6. Han, A. Y., Kuan, E. C., Alonso, J. E., Badran, K. W., & St John, M. A. (2017). Epidemiology of Nasopharyngeal Lymphoma in the United States: A Population-Based Analysis of 1119 Cases. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery, 156(5), 870–876. https://doi.org/10.1177/0194599817695808
  7. King, A. D., Yuen, E. H., Lei, K. I., Ahuja, A. T., & Van Hasselt, A. (2004). Non-Hodgkin lymphoma of the larynx: CT and MR imaging findings. AJNR. American journal of neuroradiology, 25(1), 12–15.
  8. Zucca, E., Conconi, A., & Cavalli, F. (2002). Treatment of extranodal lymphomas. Best practice & research. Clinical haematology, 15(3), 533–547. https://doi.org/10.1053/beha.2002.0218
  9. Arcega, R. S., Feinstein, A. J., Bhuta, S., Blackwell, K. E., Rao, N. P., & Pullarkat, S. T. (2015). An unusual initial presentation of mantle cell lymphoma arising from the lymphoid stroma of warthin tumor. Diagnostic pathology, 10, 209. https://doi.org/10.1186/s13000-015-0444-4
  10. Boland, G. W., Blake, M. A., Holalkere, N. S., & Hahn, P. F. (2009). PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR. American journal of roentgenology, 192(4), 956–962. https://doi.org/10.2214/AJR.08.1431
  11. Lam, P. D., Kuribayashi, A., Sakamoto, J., Nakamura, S., Harada, H., & Kurabayashi, T. (2017). Imaging findings of childhood B-cell lymphoblastic lymphoma in the mental region: a case report. Dento maxillo facial radiology, 46(3), 20160313. https://doi.org/10.1259/dmfr.20160313
  12. Schrepfer, T., Haerle, S. K., Strobel, K., Schaefer, N., Hälg, R. A., & Huber, G. F. (2010). The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. The Laryngoscope, 120(5), 937–944. https://doi.org/10.1002/lary.20843
  13. Hutchings, M., & Barrington, S. F. (2009). PET/CT for therapy response assessment in lymphoma. Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 50 Suppl 1, 21S–30S. https://doi.org/10.2967/jnumed.108.057190
  14. Dang, N., Xu, W., Song, X., Dai, D., Zhu, L., Zhu, X., Ma, W., & Wang, J. (2014). Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 35(1), 35–39. https://doi.org/10.3760/cma.j.issn.0253-2727.2014.01.009
  15. Byun, B. H., Na, I. I., Cheon, G. J., Kang, H. J., Kim, K. M., Lee, S. S., Ryoo, B. Y., Choi, C. W., Lim, S. M., & Yang, S. H. (2008). Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study. Annals of nuclear medicine, 22(8), 645–651. https://doi.org/10.1007/s12149-008-0181-9
  16. Schöder, H., Noy, A., Gönen, M., Weng, L., Green, D., Erdi, Y. E., Larson, S. M., & Yeung, H. W. (2005). Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 23(21), 4643–4651. https://doi.org/10.1200/JCO.2005.12.072
  17. Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I., Connors, J. M., Lister, T. A., Vose, J., Grillo-López, A., Hagenbeek, A., Cabanillas, F., Klippensten, D., Hiddemann, W., Castellino, R., Harris, N. L., Armitage, J. O., Carter, W., Hoppe, R., & Canellos, G. P. (1999). Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 17(4), 1244. https://doi.org/10.1200/JCO.1999.17.4.1244
  18. Ohtsuka, T., Nomori, H., Watanabe, K., Kaji, M., Naruke, T., Suemasu, K., & Uno, K. (2006). Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma. Cancer, 107(10), 2468–2473. https://doi.org/10.1002/cncr.22268
  19. Rodriguez, M., Rehn, S., Ahlström, H., Sundström, C., & Glimelius, B. (1995). Predicting malignancy grade with PET in non-Hodgkin's lymphoma. Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 36(10), 1790–1796.
  20. Wiggins RH, Hoffman JM, Fine GC, Covington MF, Salem AE, Koppula BR, Morton KA. (2022). PET-CT in Clinical Adult Oncology-V. Head and Neck and Neuro Oncology. Cancers (Basel), 14(11), 2726.
  21. Suh, C., Kang, Y. K., Roh, J. L., Kim, M. R., Kim, J. S., Huh, J., Lee, J. H., Jang, Y. J., & Lee, B. J. (2008). Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck. Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 49(11), 1783–1789. https://doi.org/10.2967/jnumed.108.053355
  22. Han, A. Y., Kuan, E. C., Alonso, J. E., Badran, K. W., & St John, M. A. (2017). Epidemiology of Nasopharyngeal Lymphoma in the United States: A Population-Based Analysis of 1119 Cases. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery, 156(5), 870–876. https://doi.org/10.1177/0194599817695808
  23. Hutchings, M., & Barrington, S. F. (2009). PET/CT for therapy response assessment in lymphoma. Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 50 Suppl 1, 21S–30S. https://doi.org/10.2967/jnumed.108.057190
  24. Schöder, H., Noy, A., Gönen, M., Weng, L., Green, D., Erdi, Y. E., Larson, S. M., & Yeung, H. W. (2005). Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 23(21), 4643–4651. https://doi.org/10.1200/JCO.2005.12.072
  25. Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I., Connors, J. M., Lister, T. A., Vose, J., Grillo-López, A., Hagenbeek, A., Cabanillas, F., Klippensten, D., Hiddemann, W., Castellino, R., Harris, N. L., Armitage, J. O., Carter, W., Hoppe, R., & Canellos, G. P. (1999). Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 17(4), 1244. https://doi.org/10.1200/JCO.1999.17.4.1244
  26. Rodriguez, M., Rehn, S., Ahlström, H., Sundström, C., & Glimelius, B. (1995). Predicting malignancy grade with PET in non-Hodgkin's lymphoma. Journal of nuclear medicine: official publication, Society of Nuclear Medicine, 36(10), 1790–1796.